Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1947 1
1948 5
1949 3
1950 9
1951 8
1952 20
1953 13
1954 17
1955 18
1956 23
1957 22
1958 17
1959 19
1960 18
1961 14
1962 22
1963 33
1964 52
1965 28
1966 38
1967 38
1968 38
1969 40
1970 31
1971 34
1972 27
1973 22
1974 25
1975 29
1976 18
1977 30
1978 39
1979 28
1980 41
1981 52
1982 60
1983 82
1984 79
1985 97
1986 94
1987 128
1988 118
1989 133
1990 159
1991 162
1992 162
1993 164
1994 179
1995 174
1996 211
1997 186
1998 204
1999 236
2000 275
2001 276
2002 324
2003 312
2004 334
2005 391
2006 404
2007 442
2008 408
2009 488
2010 488
2011 522
2012 508
2013 510
2014 580
2015 578
2016 552
2017 568
2018 590
2019 583
2020 625
2021 684
2022 694
2023 623
2024 368

Text availability

Article attribute

Article type

Publication date

Search Results

14,267 results

Results by year

Filters applied: . Clear all
Page 1
Update on follicular lymphoma.
Friedberg JW. Friedberg JW. Hematol Oncol. 2023 Jun;41 Suppl 1(Suppl 1):43-47. doi: 10.1002/hon.3138. Hematol Oncol. 2023. PMID: 37294960 Free PMC article. Review.
This update will focus on progress in follicular lymphoma over the past 3 years, which has included refinements in staging and prognosis, novel immunotherapy treatment approaches for relapsed and refractory disease, and long-term follow-up of pivotal trials. ...Thro …
This update will focus on progress in follicular lymphoma over the past 3 years, which has included refinements in staging and …
Follicular lymphoma: 2020 update on diagnosis and management.
Freedman A, Jacobsen E. Freedman A, et al. Am J Hematol. 2020 Mar;95(3):316-327. doi: 10.1002/ajh.25696. Epub 2019 Dec 22. Am J Hematol. 2020. PMID: 31814159 Free article. Review.
DISEASE OVERVIEW: Follicular lymphoma (FL) is generally an indolent B cell lymphoproliferative disorder of transformed follicular center B cells. Follicular lymphoma is characterized by diffuse lymphadenopathy, bone marrow involvement, and splen …
DISEASE OVERVIEW: Follicular lymphoma (FL) is generally an indolent B cell lymphoproliferative disorder of transformed foll
Follicular lymphoma: an update on diagnosis, prognosis, and management.
Mozas P, Sorigué M, López-Guillermo A. Mozas P, et al. Med Clin (Barc). 2021 Nov 12;157(9):440-448. doi: 10.1016/j.medcli.2021.03.041. Epub 2021 Jun 29. Med Clin (Barc). 2021. PMID: 34210513 Review. English, Spanish.
Follicular lymphoma, the most common indolent lymphoma, originates from germinal centre B-cells of the lymphoid follicle, and is characterized by t(14;18). ...Although overall survival for most patients is prolonged, relapses are very frequent, and early rela
Follicular lymphoma, the most common indolent lymphoma, originates from germinal centre B-cells of the lymphoid follicl
Epidemiology of Follicular Lymphoma.
Cerhan JR. Cerhan JR. Hematol Oncol Clin North Am. 2020 Aug;34(4):631-646. doi: 10.1016/j.hoc.2020.02.001. Epub 2020 May 5. Hematol Oncol Clin North Am. 2020. PMID: 32586570 Free PMC article. Review.
Follicular lymphoma (FL) is a common indolent lymphoma subtype in Western countries. ...
Follicular lymphoma (FL) is a common indolent lymphoma subtype in Western countries. ...
Follicular lymphoma.
Carbone A, Roulland S, Gloghini A, Younes A, von Keudell G, López-Guillermo A, Fitzgibbon J. Carbone A, et al. Nat Rev Dis Primers. 2019 Dec 12;5(1):83. doi: 10.1038/s41572-019-0132-x. Nat Rev Dis Primers. 2019. PMID: 31831752 Review.
Follicular lymphoma (FL) is a systemic neoplasm of the lymphoid tissue displaying germinal centre (GC) B cell differentiation. FL represents ~5% of all haematological neoplasms and ~20-25% of all new non-Hodgkin lymphoma diagnoses in western countries. Tumori
Follicular lymphoma (FL) is a systemic neoplasm of the lymphoid tissue displaying germinal centre (GC) B cell differentiation.
Follicular lymphoma: The long and winding road leading to your cure?
Gordon MJ, Smith MR, Nastoupil LJ. Gordon MJ, et al. Blood Rev. 2023 Jan;57:100992. doi: 10.1016/j.blre.2022.100992. Epub 2022 Jul 23. Blood Rev. 2023. PMID: 35908982 Review.
Follicular lymphoma, the most common indolent lymphoma, though highly responsive to therapy is coupled with multiple relapses for the majority of patients. ...The most exciting data currently involve immune attack against follicular lymphoma by
Follicular lymphoma, the most common indolent lymphoma, though highly responsive to therapy is coupled with multiple re
Toward a Cure for Follicular Lymphoma.
Friedberg JW. Friedberg JW. Hematol Oncol Clin North Am. 2020 Aug;34(4):xiii-xiv. doi: 10.1016/j.hoc.2020.05.001. Epub 2020 May 20. Hematol Oncol Clin North Am. 2020. PMID: 32586582 No abstract available.
Follicular lymphoma grade 3: a comprehensive review.
Alshaibani A, El Fakih R, Sureda A, Kharfan-Dabaja MA, Aljurf M. Alshaibani A, et al. Clin Adv Hematol Oncol. 2022 Jun;20(6):384-390. Clin Adv Hematol Oncol. 2022. PMID: 35731609 Review.
Follicular lymphoma (FL) is a heterogeneous entity with disparate outcomes based on clinical and pathologic characteristics. ...Although a general consensus exists that FL3B follows an aggressive course matching that of diffuse large B-cell lymphoma, there is
Follicular lymphoma (FL) is a heterogeneous entity with disparate outcomes based on clinical and pathologic characteristics. .
Early Progressing Follicular Lymphoma.
Wallace D, Casulo C. Wallace D, et al. Curr Oncol Rep. 2021 Nov 19;23(12):149. doi: 10.1007/s11912-021-01126-7. Curr Oncol Rep. 2021. PMID: 34797453 Review.
PURPOSE OF REVIEW: Follicular lymphoma is an indolent lymphoma which does not limit life expectancy in most patients; however, approximately 20% of patients will experience progression of disease within 24 months (POD24) of diagnosis and have inferior surviva …
PURPOSE OF REVIEW: Follicular lymphoma is an indolent lymphoma which does not limit life expectancy in most patients; h …
Follicular Lymphoma: Diagnostic and Prognostic Considerations in Initial Treatment Approach.
Boughan KM, Caimi PF. Boughan KM, et al. Curr Oncol Rep. 2019 May 23;21(7):63. doi: 10.1007/s11912-019-0808-0. Curr Oncol Rep. 2019. PMID: 31119485 Review.
PURPOSE OF REVIEW: Follicular lymphoma is a diverse disease, with a diverse variable biology, clinical presentation, and prognosis. The identification of factors that can predict the specific outcome of follicular lymphoma patients remains an area of n …
PURPOSE OF REVIEW: Follicular lymphoma is a diverse disease, with a diverse variable biology, clinical presentation, and progn …
14,267 results
You have reached the last available page of results. Please see the User Guide for more information.